Never Too Late: if you missed the IPKat last week from ipkitten.blogspot.com Were you too busy hiding from Cruella de Vil and her goons to read the IPKat last week? Not to worry, the 101st edition of Never Too Late is here to bring you up to ...
Share via E–mail | Twitter | Facebook
Neighbouring rights for publishers: are national and (possible) EU initiatives lawful? from ipkitten.blogspot.com ... or, in alternative,
to introduce an EU-wide neighbouring right
for publishersOver the past few years debate has ensued at the level of EU Member States and the EU alike on how to address declining ... Share via E–mail | Twitter | Facebook
Cuozzo Speed Technologies, LLC v. Lee (2016) -- Question 2 -- PTAB Shenanigans and Reviewability from www.patentdocs.org By Andrew Williams -- The saga of the first-filed IPR petition (IPR2012-00001) came to a close today when the Supreme Court decided the Cuozzo Speed Technologies, LLC v. Lee case. We have been following this case ...
Share via E–mail | Twitter | Facebook
Cherry picking and smushing references together from www.717madisonplace.com Patent prosecutors — and applicants disillusioned with the patent process — will be particularly receptive to the comments that Judge Moore made during the recent oral argument of In re Neill. During that oral argument Judge Moore ...
Share via E–mail | Twitter | Facebook
Airbus (the COMPANY, not a plane) hijacked by patent extremists, joined trolls' lobbying entity named IP Europe from www.fosspatents.com With respect to standard-essential patent licensing, my preferred European voice of reason(ableness) is the Fair Standards Alliance, an organization Google recently joined and which I'd like to see Apple and Samsung team up ...
Share via E–mail | Twitter | Facebook
Nearly All Global Physical Counterfeiting Is From China & Hong Kong, US Report Shows from www.ip-watch.org A new analysis released this week by the United States Chamber of Commerce Global Intellectual Property Center (GIPC) shows that some 86 percent of all physical counterfeiting comes from China and Hong Kong. Companies locating ...
Share via E–mail | Twitter | Facebook
Asserted Claims of Attention Management Patent Invalid Under 35 U.S.C. § 101 from docketreport.blogspot.com The court granted defendant's motion for judgment on the pleadings that the asserted claims of plaintiff’s attention management patent encompassed unpatentable subject matter and found that the claims were directed toward an abstract ...
Share via E–mail | Twitter | Facebook
WTO Reports On IP Trends In G20 Countries from www.ip-watch.org As part of a larger report on the G20 top global economies, the World Trade Organization has provided a discussion of policy developments in trade and intellectual property. This includes a look at international policy ...
Share via E–mail | Twitter | Facebook
Federal Circuit Saves Patentees by ruling that “Before” includes “Just Afterwards” from patentlyo.com by Dennis Crouch Immersion Corp. v. HTC Corp. (Fed. Cir. 2016) [ImmersionHTC] Sometimes one day makes a big difference – especially if accidentally missed yesterday’s deadline (or if you misread the statute). The case here ...
Share via E–mail | Twitter | Facebook
US High Court Inter Partes Review Leaves Patent Holders Dissatisfied from www.ip-watch.org A 20 June decision by the Supreme Court upholding US Patent and Trademark Office (USPTO) rules for inter partes review of patents isn't helpful to patent owners, according to several attorneys. The ruling in ...
Share via E–mail | Twitter | Facebook
Supreme Court Calls for Views of the Solicitor General from patentlyo.com The no-change decision in Cuozzo was the biggest immediate patent law news from June 20, 2016. However, two other actions by the court that day may end up having a greater long term impact. Namely ...
Share via E–mail | Twitter | Facebook
Amgen v. Sandoz Update -- Supreme Court Seeks Views of United States from www.patentdocs.org By Andrew Williams -- In other Supreme Court news from Monday, June 20, 2016, the Court invited the Solicitor General to file briefs in the Sandoz v. Amgen (No. 15-1039) and Amgen v. Sandoz (No. 15-1195 ...
Share via E–mail | Twitter | Facebook